Teleflex reported strong revenue and EPS growth, driven by the Interventional segment and strategic acquisitions, while facing pressures in EMEA and specific product lines like UroLift and Anesthesia. The significant tariff mitigation and strategic initiatives, including the BIOTRONIK acquisition, contribute positively to future growth prospects.

Company Guidance -

Q3 2025

During the Teleflex Second Quarter 2025 Earnings Conference Call, the company provided updated financial guidance for 2025. The second quarter revenues reached $780.9 million, which was a 4.2% increase year-over-year on a GAAP basis and exceeded the high end of the previous guidance range. Adjusted earnings per share for the quarter were $3.73, marking a 9.1% increase year-over-year. The guidance for total constant currency growth in 2025 was updated to a range of 7.7% to 8.7%, factoring in the recent acquisition of BIOTRONIK's Vascular Intervention business, which is expected to contribute $204 million in revenue in the second half of the year. The company also adjusted its GAAP revenue growth expectations to 9% to 10% and raised its adjusted earnings per share guidance by $0.70, reflecting operational performance and tariff mitigation efforts. Additionally, they anticipate adjusted gross margins to be in the range of 58.75% to 59.5%, benefiting from reduced tariff impacts and strategic operational adjustments.

Revenue and EPS Exceed Expectations

Second quarter revenues were $780.9 million, a 4.2% increase year-over-year, exceeding the high end of previous guidance. Adjusted EPS increased by 9.1% year-over-year to $3.73.

Interventional Segment Performance

Interventional revenue was $170 million, up 19.3% year-over-year, led by growth drivers such as intra-aortic balloon pumps and complex catheters.

Strategic Acquisition

Completed the acquisition of BIOTRONIK's Vascular Intervention business, expected to generate $800 million plus in annual revenues.

Positive Tariff Impact

Expected tariff impact reduced from $55 million to $29 million for 2025, contributing $0.50 to EPS improvement.

Progress in Clinical Studies and Product Innovation

Promising results from the study on chlorhexidine-impregnated CVCs and Titan SGS stapler, supporting their efficacy and potential for market penetration.

Teleflex (TFX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TFX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	3.40 / -	3.49	―	―	―
Jul 31, 2025	2025 (Q2)	3.36 / 3.73	3.42	9.06% (+0.31)
May 01, 2025	2025 (Q1)	2.88 / 2.91	3.21	-9.35% (-0.30)
Feb 27, 2025	2024 (Q4)	3.86 / 3.89	3.38	15.09% (+0.51)
Oct 31, 2024	2024 (Q3)	3.39 / 3.49	3.64	-4.12% (-0.15)
Aug 01, 2024	2024 (Q2)	3.33 / 3.42	3.41	0.29% (<+0.01)
May 02, 2024	2024 (Q1)	3.08 / 3.21	3.09	3.88% (+0.12)
Feb 22, 2024	2023 (Q4)	3.26 / 3.38	3.52	-3.98% (-0.14)
Nov 02, 2023	2023 (Q3)	3.27 / 3.64	3.27	11.31% (+0.37)
Aug 03, 2023	2023 (Q2)	3.21 / 3.41	3.39	0.59% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TFX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$113.91	$119.50	+4.91%
May 01, 2025	$136.69	$125.54	-8.16%
Feb 27, 2025	$176.72	$138.39	-21.69%
Oct 31, 2024	$233.59	$199.67	-14.52%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Teleflex Inc (TFX) report earnings?

Teleflex Inc (TFX) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).

What is Teleflex Inc (TFX) earnings time?

Teleflex Inc (TFX) earnings time is at Oct 23, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TFX EPS forecast?

TFX EPS forecast for the fiscal quarter 2025 (Q3) is 3.4.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing